Document ID: chunk:federal_register_of_legislation:F2024C00993:reg:27:p1
Version: federal_register_of_legislation:F2024C00993
Segment Type: reg
Provision Reference: reg 27 (pt 1/5)
Character Range: 31562–37048

27  Application of the Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022
 (1) This section applies in relation to a person who was, immediately before 1 October 2022, eligible to participate in the Scheme.
 (2) Despite the amendments made by Schedule 1 to the Continence Aids Payment Scheme Amendment (Eligibility) Instrument 2022, this instrument, as in force immediately before 1 October 2022, continues to apply to the person until the end of 30 June 2023.

Schedule

Part 1—Eligible neurological condition

Category 1  CONGENITAL MORPHOLOGICAL DISORDERS
            Agenesis of Corpus Callosum
            Anorectal Malformation
            Apert Syndrome
            Arnold‑Chiari Syndrome
            Arthrogryposis
            Bladder Exstrophy
            Caudal agenesis
            Caudal Regression Syndrome
            Cerebral Neuronal Migration Disorders
            Charge Syndrome
            Cloacal Exstrophy
            Congenital Epispadias
            Congenital Hydrocephalus
            Dandy‑Walker malformation
            Developmental Cord Disorder
            Hirschsprung's Disease
            Holoprosencephaly
            Imperforate Anus
            Incomplete Corpus Callosum/Aicardi Syndrome
            Lissencephaly
            Megalencephaly
            Microcephaly
            Neural tube defect
            Polymicrogyria
            Pontocerebellar Hypoplasia
            Posterior Urethral Valve Syndrome
            Prune Belly Syndrome
            Sacral Agenesis
            Schizencephaly
            Spinal Agenesis
            Spinal Dysraphism
            Spinal Hemangioma
            Syringobulbia
            Syringomyelia
            Tethered spinal cord
            Vater Syndrome/Vacterl Syndrome
            Velocardiofacial Syndrome

Category 2  CEREBRAL PALSY
            Dystonic Cerebral Palsy
            Hereditary Spastic Paralysis
            Spastic Quadriplegia
            Mixed cerebral palsy

Category 3  SYNDROMES ASSOCIATED WITH INTELLECTUAL IMPAIRMENT
            2‑Hydroxyglutaric Aciduria
            Alpers Disease
            Angelman Syndrome
            Alpha Thalassaemia X‑linked intellectual disability Syndrome
            Bardet Biedl Syndrome
            Beare‑Stevenson Syndrome
            Cyclin Dependent Kinase‑Like 5 Gene Mutation
            Chime Syndrome
            Chromosome 1 Deletion
            Chromosome 5q deletion (Cri Du Chat Syndrome)
            Chromosome 13q Deletion Syndrome
            Chromosome 15q Duplication Syndrome
            Chromosome 18q Deletion Syndrome
            Chromosome 1p36 Deletion Syndrome/Mono 1p36
            Chromosome 22 Ring
            Chromosome 2q Deletion Syndrome
            Chromosome 6 Ring Syndrome
            Chromosome 8  Inversion or Duplication
            Chromosome 9p Deletion Syndrome
            Chromosome 9q Deletion Syndrome
            Chromosome 11q (Jacobsen Syndrome)
            Chromosome Xp Duplication
            Cockayne Syndrome
            Coffin‑Lowry Syndrome
            Cognitive Impairment
            Cohen Syndrome
            Congenital disorders of glycosylation
            Congenital Neurological Infections
            Cornelia de Lange Syndrome
            Costello Syndrome
            Cowden Disease
            Developmental Delay
            Developmental Delay associated with Autism, Autism Spectrum Disorder and Aspergers Syndrome
            Dravet Syndrome
            Fragile X Syndrome
            Fumarase Deficiency
            GLUT1‑Deficiency Syndrome
            Glutaric Aciduria Type 1
            Goldenhar's Syndrome
            Hunter Syndrome
            Hurler‑Scheie Syndrome
            Hypomyelination disorders
            Joubert Syndrome
            Kabuki Syndrome
            Langer‑Gideon Syndrome
            Lawrence Moon Biedel Syndrome
            Lennox‑Gastaut Syndrome
            Lesch‑Nyhan Syndrome
            Lowe Syndrome
            Mannosidosis
            Maple Syrup Urine Disease
            Meningitis
            Menkes Syndrome
            Mitochondrial Dieases
            Molybdenum Cofactor Deficiency
            Mowat‑Wilson Syndrome
            Mucolipidosis IV
            Myotonic Dystrophy (Type 1)
            Neonatal Hypoxic ischaemic encephalopathy
            Neonatal Onset Multisystem Inflammatory Disease
            Neuronal ceroid lipofuscinosis
            Normal Pressure Hydrocephalus
            OHDO Syndrome
            Opitz Trigonocephaly Syndrome
            Ohtahara Syndrome
            Ouvrier Syndrome
            Pallister‑Killian Mosaic Syndrome
            Peroxisome Biogenesis Disorder
            Phelan McDermid Syndrome/22q 13 Deletion Syndrome
            Phenylketonuria
            Prader‑Willi Syndrome
            Pyruvate Dehydrogenase Deficiency/Leigh's Disease
            Rasmussen's Disease
            Rett Syndrome
            Rubinstein‑Taybi Syndrome
            Sensory Integration Disorder/Dysfunction
            Smith‑Lemli‑Opitz Syndrome
            Smith‑Magenis Syndrome
            Sotos Syndrome
            Sturge‑Weber Syndrome
            Subcortical Band Heterotopia
            Translocation of Chromosome 2
            Translocation Trisomy 5/18
            Trichothiodystrophy
            Triploidy
            Trisomy 10
            Trisomy 13 (Patau syndrome)
            Trisomy 18 (Edward Syndrome)
            Trisomy 20p
            Trisomy 21 (Down